We are live on ! Find out more
NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

1 hedge funds and large institutions have $138K invested in NKGen Biotech, Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

55% less capital invested

Capital invested by funds: $303K → $138K (-$165K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NKGN Hedge Fund Activity: Q4 2025 in Review

1 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Common Stock (NKGN) for Q4 2025, worth a combined $138K — down 55% from $303K a quarter earlier.

Fund positioning in NKGN was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held NKGen Biotech, Inc. Common Stock (NKGN) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $138K of NKGen Biotech, Inc. Common Stock stock for Q4 2025, down 55% quarter-over-quarter.
  • 0 funds opened new NKGen Biotech, Inc. Common Stock positions in Q4 2025 and 0 closed out.

Based on aggregated 13F filings for Q4 2025.